Literature DB >> 15558346

Nosocomial lower respiratory tract infections: prevalence and risk factors in 14 Greek hospitals.

D P Kofteridis1, J A Papadakis, D Bouros, P Nikolaides, G Kioumis, S Levidiotou, E Maltezos, S Kastanakis, S Kartali, A Gikas.   

Abstract

Nosocomial lower respiratory tract infections (NLRTIs) are associated with significant morbidity and mortality. The aim of this study was to investigate the epidemiological features of NLRTIs in Greece, where knowledge about these infections is limited. Two point-prevalence studies of hospital-acquired infections were carried out in 14 Greek hospitals located throughout the country, one in 1999 and one in 2000. NLRTIs were diagnosed in accordance with the Centers for Disease Control and Prevention (CDC) definitions. Among the 7,120 hospitalized patients registered during the two studies, 610 (8.6%) cases of hospital-acquired infections were identified, of which 200 (32.8%) were NLRTIs. Sixty-nine (34.5%) patients had pneumonia, and the remaining 131 (65.5%) patients had bronchitis. The greatest prevalence of NLRTI was found in the adult ICUs (30.4%). Male gender, age >65 years, mechanical ventilation, tracheostomy, an intravenous central line, and an indwelling urethral catheter were the main risk factors. There was no significant difference in the incidence of NLRTI among hospital-acquired infections between the 1999 study and the 2000 study. The causative microorganism was identified in 78 of 200 (39%) cases, and 103 strains were isolated. The majority of strains (67%) were gram-negative bacteria. The most frequently isolated microorganisms were Pseudomonas aeruginosa (22.3%), Acinetobacter spp. (19.4%), Klebsiella pneumoniae (12.6%), and Staphylococcus aureus (10.7%). There was no difference between the two prevalence studies in the frequency of isolation of the microorganisms. NLRTI was the leading cause of morbidity and mortality among hospitalized patients with hospital-acquired infections in Greek hospitals. Gram-negative microorganisms were the most frequently isolated pathogens.

Entities:  

Mesh:

Year:  2004        PMID: 15558346     DOI: 10.1007/s10096-004-1245-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  The Second National Prevalence Survey of infection in hospitals--overview of the results.

Authors:  A M Emmerson; J E Enstone; M Griffin; M C Kelsey; E T Smyth
Journal:  J Hosp Infect       Date:  1996-03       Impact factor: 3.926

Review 2.  Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1996-05       Impact factor: 21.405

3.  Risk factors for ICU-acquired pneumonia.

Authors:  D J Cook; M H Kollef
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

4.  Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group.

Authors:  H S Sader; R N Jones; A C Gales; P Winokur; K C Kugler; M A Pfaller; G V Doern
Journal:  Diagn Microbiol Infect Dis       Date:  1998-12       Impact factor: 2.803

5.  Nosocomial pneumonia. A multivariate analysis of risk and prognosis.

Authors:  R Celis; A Torres; J M Gatell; M Almela; R Rodríguez-Roisin; A Agustí-Vidal
Journal:  Chest       Date:  1988-02       Impact factor: 9.410

6.  Nosocomial pneumonia: importance of recognition of aetiological agents to define an appropriate initial empirical therapy.

Authors:  S F Costa; M Newbaer; C R Santos; M Basso; I Soares; A S Levin
Journal:  Int J Antimicrob Agents       Date:  2001-02       Impact factor: 5.283

Review 7.  The diagnosis of pneumonia in the critically ill.

Authors:  C S Garrard; C D A'Court
Journal:  Chest       Date:  1995-08       Impact factor: 9.410

8.  Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients.

Authors:  A Torres; A Martos; J Puig de la Bellacasa; M Ferrer; M el-Ebiary; J González; A Gené; R Rodríguez-Roisin
Journal:  Am Rev Respir Dis       Date:  1993-04

9.  Urinary-tract infection and bacteraemia in hospitalized medical patients--a European multicentre prevalence survey on nosocomial infection.

Authors:  O B Jepsen; S O Larsen; J Dankert; F Daschner; P Grönroos; P D Meers; B Nyström; M Rotter; J Sander
Journal:  J Hosp Infect       Date:  1982-09       Impact factor: 3.926

10.  Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia.

Authors:  P Montravers; J Y Fagon; J Chastre; M Lecso; M C Dombret; J L Trouillet; C Gibert
Journal:  Am Rev Respir Dis       Date:  1993-01
View more
  15 in total

1.  Impact of sex and ozone exposure on the course of pneumonia in wild type and SP-A (-/-) mice.

Authors:  Anatoly N Mikerov; Sanmei Hu; Faryal Durrani; Xiaozhuang Gan; Guirong Wang; Todd M Umstead; David S Phelps; Joanna Floros
Journal:  Microb Pathog       Date:  2012-01-20       Impact factor: 3.738

2.  Weather impacts on respiratory infections in Athens, Greece.

Authors:  Panagiotis T Nastos; Andreas Matzarakis
Journal:  Int J Biometeorol       Date:  2006-04-05       Impact factor: 3.787

3.  The Lung Alveolar Cell (LAC) miRNome and Gene Expression Profile of the SP-A-KO Mice After Infection With and Without Rescue With Human Surfactant Protein-A2 (1A0).

Authors:  Nithyananda Thorenoor; Joanna Floros
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

4.  Clinical Evaluation of the New High-Throughput Luminex NxTAG Respiratory Pathogen Panel Assay for Multiplex Respiratory Pathogen Detection.

Authors:  Jonathan H K Chen; Ho-Yin Lam; Cyril C Y Yip; Sally C Y Wong; Jasper F W Chan; Edmond S K Ma; Vincent C C Cheng; Bone S F Tang; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2016-04-27       Impact factor: 5.948

5.  Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa.

Authors:  Tanja Kerber-Momot; Damaris Leemhuis; Anke Lührmann; Antje Munder; Burkhard Tümmler; Reinhard Pabst; Thomas Tschernig
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

6.  Lipocalin 2 is required for pulmonary host defense against Klebsiella infection.

Authors:  Yvonne R Chan; Jessica S Liu; Derek A Pociask; Mingquan Zheng; Timothy A Mietzner; Thorsten Berger; Tak W Mak; Matthew C Clifton; Roland K Strong; Prabir Ray; Jay K Kolls
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Sex differences in the response of the alveolar macrophage proteome to treatment with exogenous surfactant protein-A.

Authors:  David S Phelps; Todd M Umstead; Joanna Floros
Journal:  Proteome Sci       Date:  2012-07-23       Impact factor: 2.480

8.  Ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differences.

Authors:  Anatoly N Mikerov; Rizwanul Haque; Xiaozhuang Gan; Xiaoxuan Guo; David S Phelps; Joanna Floros
Journal:  Respir Res       Date:  2008-12-04

9.  Sex differences in the impact of ozone on survival and alveolar macrophage function of mice after Klebsiella pneumoniae infection.

Authors:  Anatoly N Mikerov; Xiaozhuang Gan; Todd M Umstead; Laura Miller; Vernon M Chinchilli; David S Phelps; Joanna Floros
Journal:  Respir Res       Date:  2008-02-28

10.  Status and perspectives of hospital mortality in a public urban Hellenic hospital, based on a five-year review.

Authors:  Iordanis N Papadopoulos; Maria Papaefthymiou; Leonidas Roumeliotis; Vasilios G Panagopoulos; Anna Stefanidou; Anastasia Kostaki
Journal:  BMC Public Health       Date:  2008-01-23       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.